Echocardiography in Hypertrophic Cardiomyopathy The Role of Conventional and Emerging Technologies by Afonso, Luis C. et al.
FE
H
T
L
T
D
H
l
f
n
r
t
s
h
o
H
n
s
a
t
t
m
t
c
d
a
t
g
a
s
d
p
F
L
M
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 1 , N O . 6 , 2 0 0 8
© 2 0 0 8 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / 0 8 / $ 3 4 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c m g . 2 0 0 8 . 0 9 . 0 0 2R O M P I C T U R E S T O P R A C T I C E P A R A D I G M S
chocardiography in
ypertrophic Cardiomyopathy
he Role of Conventional and Emerging Technologies
uis C. Afonso, MD, FACC,* Juan Bernal, MD,* Jeroen J. Bax, MD,†
heodore P. Abraham, MD, FACC‡
etroit, Michigan; Leiden, the Netherlands; and Baltimore, Maryland
ypertrophic cardiomyopathy is a relatively common inherited cardiomyopathy that is occasionally chal-
enging to differentiate fromhypertensive heart disease and athlete hearts on the basis ofmorphologic or
unctional abnormalities alone. Echocardiography has traditionally played a preeminent role in the diag-
osis, formulation of management strategies, and the prognostication of this complex disease. In this
eview, we briefly profile the utility and pitfalls of established echocardiographic modalities and discuss
he evolving role of novel echocardiographic imaging modalities such as tissue Doppler, Doppler-based
train, 2-dimensional strain (speckle tracking imaging), and 3-dimensional imaging in the assessment of
ypertrophic cardiomyopathy. (J Am Coll Cardiol Img 2008;1:787–800) © 2008 by the American College
f Cardiology Foundationp
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Hopypertrophic cardiomyopathy (HCM) is a ge-
etically heterogeneous disease resulting from
arcomeric protein mutations (1–6) and char-
cterized by inappropriate myocardial hyper-
rophy (without identifiable etiology), intersti-
ial fibrosis, myofiber disarray, disorganized
yocardial architecture, and impaired left ven-
ricular (LV) performance (7). This complex
ondition, typified by phenotypic and clinical
iversity, tends to afflict patients of all ages.
Historically, 2-dimensional (2D), M-mode,
nd Doppler echocardiography have been key
o the noninvasive diagnosis of HCM. To-
ether, these fundamental modalities allow for
composite assessment of the morphology,
tructural abnormalities, and hemodynamic
isturbances in HCM, some of which have
rofound prognostic value (8,9).
rom the *Division of Cardiology, Wayne State University, Detro
eiden, the Netherlands; and the ‡Division of Cardiology, Johnsanuscript received May 30, 2008; revised manuscript received AugusAlthough global systolic function is typically
reserved or hyperdynamic in HCM (10),
agnetic resonance myocardial tagging studies
rst demonstrated heterogeneity of myocardial
eformation in HCM, reflecting regional vari-
tions in myofiber disarray and fibrosis charac-
eristic of this condition (11,12).
Left ventricular contraction is characterized
y complex 3-dimensional (3D) deformation
f the myocardium, including longitudinal
yofiber shortening, radial thickening, circum-
erential shortening and LV twist or torsion
i.e., basal clockwise rotation coupled with
pical anticlockwise rotation when viewed from
he apex). After ejection, recoil of torsional
eformation results in untwisting coincident
ith isovolumic relaxation and generates the
entricular suction force that accompanies early
ichigan; †Division of Cardiology, University of
kins University, Baltimore, Maryland.t 27, 2008, accepted September 5, 2008.
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788iastolic relaxation (13). The myocardium is com-
osed of a highly aligned continuum of muscle
bers whose orientation relative to the long axis of
he ventricle depends on their transmural location.
lthough midmyocardial fibers maintain a predom-
nantly circumferential orientation, the epicardial
elical fibers course obliquely toward the apex
hereas subendocardial helical fibers course ob-
iquely to the base (14). This geometrical orienta-
ion of myofibers allows for maximal fiber strain
omogeneity during ejection (15).
The evolution of newer ultrasound-based technol-
gies such as tissue Doppler, strain imaging, speckle
racking-based LV torsion analysis, and 3D echocar-
iography (3D-E) has revolutionized the assessment
of cardiac performance from mere assess-
ment of ejection fraction to a more sophis-
ticated appraisal of regional cardiac mechan-
ics (16 –19). Specifically, the complex
deformations that constitute systolic con-
traction, including ventricular twist; longitu-
dinal, circumferential, and radial displace-
ment; velocities; strain; and strain rate can
now be reliably quantified (20–25). These
novel technologies have provided profound
mechanistic insight into abnormalities of
regional contractility and diastolic function
and have enabled the noninvasive character-
ization of abnormal intramural myocardial
mechanics emblematic of HCM. In addi-
tion, these advances have facilitated pre-
clinical diagnosis (26,27), refined risk strat-
ification (28 –30), and furthered our
understanding of existing therapies for
HCM (31,32). In this review, we briefly
discuss conventional echocardiographic
techniques and elaborate on the evolving
role of newer echo imaging modalities in the
assessment of HCM.
eneral Considerations
ypertrophic cardiomyopathy is characterized by
symmetric left ventricular hypertrophy, typically
nvolving the septum, but almost any myocardial
egment may be involved. Compared with nonapi-
al variants, the apical hypertrophic phenotype has a
eputation for being misdiagnosed or under-
ecognized on 2D echocardiography (33). Septal
hickness 15 mm and a septal to posterior free
all ratio (interventricular septum/posterior wall
atio)1.3 have been traditionally considered time-
n
ow
ion
gonored diagnostic criteria for the diagnosis of ssymmetrical septal hypertrophy (34). It is impor-
ant to recognize however, that asymmetric left
entricular hypertrophy (LVH) in itself is not pa-
hognomonic of HCM but may be encountered in
variety of congenital or acquired conditions, in-
luding right ventricular hypertension, systemic hy-
ertension, aortic stenosis, septal sarcomas, Fabry
isease, Freidreich’s ataxia, mucopolysaccharide or
lycogen storage disorders, amyloidosis and, on
ccasion, mistakenly diagnosed as a result of tech-
ical challenges inherent with cross-sectional imag-
ng (35).
ystolic Anterior Motion (SAM)
ystolic anterior motion of the anterior mitral leaflet
ith or without a pressure gradient across the left
entricular outflow tract (LVOT), although not pa-
hognomonic, is highly indicative of HCM, with a
pecificity approaching 98% (Fig. 1B) (36). Initially,
elieved to be due to a “Venturi” effect, it has now
een demonstrated that hydrodynamic “drag” or the
pushing” force of flow might be the dominant oper-
nt mechanism, based on temporal observations of
ow and dynamic cross-sectional analysis of mitral
pparatus geometry (37). Of note, SAM may also be
ncountered in assorted conditions such as transposi-
ion of great vessels, hypercontractile states, after
itral valve repair, anomalous papillary muscle inser-
ion, anteroapical infarction with hyperkinetic basal
egments and, elderly women with LVH/sigmoid
eptum and hyperdynamic ventricular function (38).
VOT or Subaortic Obstruction
esting LVOT obstruction, defined as a peak
radient 30 mm Hg, has prognostic significance
nd is a strong predictor of death (related to HCM)
nd progression to heart failure (39). Doppler
nterrogation across the LVOT in dynamic obstruc-
ive HCM results in a characteristic signal with a
ate-peaking dagger-shaped appearance (Fig. 1D)
40,41) A midsystolic decrease in LV ejection
elocity is observed in some patients with severe
bstruction, giving rise to the characteristic “lobster
law” Doppler tracing abnormality (42), and is
aused by a truncation of LV longitudinal segmen-
al shortening (43). Most individuals with HCM do
ot exhibit resting obstruction. In symptomatic
ndividuals with resting gradients 30 mm Hg,
ttempts to provoke hemodynamic obstruction ei-
her by administering amyl nitrite, upright exercise,
r the Valsalva maneuver should be pursued. Mid-B B R E V I A T I O N S
N D A C R O N YM S
 systolic myocardial strai
MR cardiac magnetic
esonance
CM hypertrophic
ardiomyopathy
A left atrial
V left ventricular
VH left ventricular
ypertrophy
VOT left ventricular outfl
ract
a systolic mitral annular
issue velocity
AM systolic anterior mot
R strain rate
RI tissue Doppler-based
train imaging (SRI)
DI tissue Doppler imagin
D-E 3 dimensionalystolic notching, aortic valve preclosure (Fig. 1C),
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789oarse systolic fluttering of the aortic valve, and
brotic septal changes at the level of leaflet-septal
ontact are related echocardiographic features in
bstructive HCM.
ystolic Dysfunction
ystolic function typically is normal or supernormal in
bstructive and nonobstructive variants of HCM
hen ejection fraction or fractional shortening (radial
ontractile function) is used as a metric. Ejection
raction usually is preserved (10) despite significant
mpairment of longitudinal contractile function, evi-
enced by attenuation in systolic annular velocities,
train and strain rate (44). With the use of strain
maging, it is now possible to spatially map and
dentify regional heterogeneity in contractile function,
n important advance in our understanding of de-
anged myocardial mechanics in HCM.
Terminally in the disease process, myocardial fibro-
is may result in progressive impairment of systolic
unction (end-stage HCM) (45). This transformation
s characterized by myocardial thinning, systolic im-
Figure 1. Characteristic Echocardiographic Features of Obstruct
(A) Parasternal long-axis view depicting severe asymmetric septal h
M-mode across the mitral leaﬂets depicting prominent systolic ante
M-mode tracing across the aortic valve demonstrating partial closur
dynamic left ventricular outﬂow tract obstruction after the Valsalva
interventricular septum; LA  left atrium; SAM  systolic anterior mairment, cavity dilation and variably attributed to dbrotic changes in the intercellular matrix, ischemia,
nfarction, and small vessel disease. Deterioration of
ystolic function has also been associated with in-
reased mortality (up to 11% per year) and sudden
ardiac death (45).
iastolic Dysfunction
reduction of chamber compliance (increased LV
ass) and increased stiffness (myocardial fibrosis)
oupled with a reduction of ventricular volume and
uction play a role in the pathophysiology of dia-
tolic dysfunction in patients with HCM. Likewise,
egional asynchrony, post-systolic shortening, and
eterogeneity of relaxation appear to be important
nderlying contributory mechanisms. Doppler
chocardiography allows the characterization of di-
stolic abnormalities in HCM, mostly indicating
mpaired myocardial relaxation regardless of symp-
oms or the presence of LV outflow obstruction
46). Nishimura et al. (47) initially showed that
onventional Doppler parameters such as mitral E
elocity deceleration time and ratio of early to late
HCM
trophy and systolic anterior mitral valve motion (arrowhead); (B)
motion (thick arrows) of the anterior mitral leaﬂet (SAM); (C)
aortic leaﬂets (arrowheads); and (D) accentuation of late-peaking
euver. Ao  aorta; HCEM  hypertrophic cardiomyopathy; IVS 
n; PW  posterior wall ratioive
yper
rior
e of
maniastolic filling do not accurately correlate with LV
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790lling pressures in HCM. Subsequently, Doppler-
erived diastolic function parameters such as the
/E= ratio (using lateral annular tissue Doppler
elocities), color M-mode–derived flow propaga-
ion velocity (estimated by shifting the Nyquist
aseline until a distinct color border is obtained and
hen measuring the slope of its most linear compo-
ent past the valve leaflets), E/flow propagation
elocity ratio, but not pulmonary venous velocity
arameters, were shown to correlate reasonably well
ith invasive measurements of pre-A LV end-
iastolic pressure (48). These parameters also reli-
bly predict exercise tolerance (49) and reductions
n filling pressure post-septal ablation or myectomy
50). However, the authors of a recent study of
ymptomatic patients with HCM found that E/E=
irrespective of whether medial and lateral annular
elocities were used) overall correlated modestly
ith invasively derived mean left atrial pressure but
as less accurate in precisely predicting LV filling
ressure in individual patients (51). In this study,
pproximately 25% of patients with E/E= 15 had
eft atrial pressure measurements of 15 mm Hg,
llustrating the relative lack of specificity of this
atio in determining filling pressure in the setting of
CM compared with its established utility in other
opulations (52).
eft Atrial (LA) Enlargement in HCM
A volume is largely determined by the presence of
iastolic dysfunction (severity and chronicity of LA
ressure elevation), mitral regurgitation, and atrial
yopathy. Although LA enlargement as assessed
rom linear dimensions was shown to independently
redict long-term prognosis in patients with HCM
53) and post-myectomy survival in patients with
bstructive HCM (54), it is important to recognize
hat linear dimensions, particularly anteroposterior
easurements of the LA, may misrepresent true
A size, because this chamber frequently remodels
symmetrically (55). Volume determinations cir-
umvent this inherent limitation and have been
emonstrated to correlate better with cardiovascular
utcomes. The American Society of Echocardiog-
aphy recommends indexing LA volume (derived
rom biplane area length or method of disks) to
ody surface area for quantification of LA size
normal indexed LA volume 22 6 ml/m2) (56).
A volume has been found to be a long-term
ndependent indicator of functional capacity (57)
nd an LA volume index of 34 ml/m2 has been
hown to be predictive of a greater degree of LVH, beverity of diastolic dysfunction, and adverse car-
iovascular outcomes (58). Echocardiographic indi-
es of left atrial filling and relaxation (atrial me-
hanical function) have also been shown to be
mpaired in HCM in contrast to other secondary
orms of LVH, implicating a more generalized
yopathic process, not necessarily restricted to the
V myocardium (atrial myopathy) (58).
ovel Techniques
issue Doppler Imaging (TDI). TDI, a relatively new
chocardiographic modality developed for clinical
se, measures high-amplitude, low-velocity signals
f myocardial tissue motion (18). This Doppler-
ased technique allows real-time quantification of
xial or longitudinal myocardial function. During
he cardiac cycle, the apex remains stationary rela-
ive to the mitral annulus. Annular displacements
oward the apex in systole and away from the apex
n diastole represent surrogate measures of longitu-
inal ventricular contraction and relaxation,
espectively.
TDI can be performed in pulse wave or color
ode. In pulse wave interrogation, a sample
olume is placed within the ventricular myocar-
ium, immediately adjacent to the medial or
ateral annulus to record systolic and diastolic
yocardial velocities. Color TDI allows color
oding of myocardial velocities superimposed on
2D gray-scale or M-mode image. As the result
f higher spatial resolution, multiple structures or
egments can be visualized simultaneously in a
ingle field of view.
Systolic myocardial velocity, a measure of longi-
udinal systolic function, has been shown to be
ttenuated in HCM, even in nonhypertrophied
entricular segments (59). Early diastolic mitral
nnular velocity is a pre-load–independent index for
valuating diastolic function. Early mitral annular
elocities are reduced in patients with HCM com-
ared with age-matched controls and relate to the
agnitude of ventricular hypertrophy (49).
Useful diagnostic (26,60,61) as well prognostic
62) information has emerged from clinical studies
ssessing the role of TDI in patients with HCM.
irst, Nagueh et al. (26) investigated myocardial
elocities in genotype-positive individuals with
CM in the absence or presence of LVH. Com-
ared with normal controls, all individuals with
CM presented significantly reduced systolic tissue
elocities (Sa) and early diastolic tissue velocities at
oth corners of the mitral annulus. Most impor-
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791antly, mutation positive subjects without evidence
f echocardiographic LVH were accurately identi-
ed by a Sa TDI velocity of 13 cm/s in the lateral
itral annulus with a sensitivity of 100% and a
pecificity of 93%. These investigators also reported
n the utility of TDI to predict the development of
anifest HCM in mutation positive subjects with
educed TD velocities on follow-up (27).
The use of TDI also can assist in differentiating
etween variants of LVH. Vinereanu et al. (19)
sed TDI to distinguish pathological from physio-
ogical LVH in a study comprising patients with
CM, patients with systemic hypertension, ath-
etes, and normal subjects. Preserved peak systolic
nnular velocities help discriminate physiologic
VH from pathologic variants of LVH, whereas
eterogeneity of systolic mitral annular velocities
nable the differentiation of HCM (low velocities,
igh heterogeneity) from hypertensive LVH (low
elocities, low heterogeneity) (19). The authors
roposed a mean systolic annular motion Sa 9
m/s for differentiating pathological LVH (HCM/
ypertensive LVH) from physiological LVH (diag-
ostic accuracy of 92%).
A significant negative correlation also has been
bserved between TDI Sa (peak systolic), early
iastolic mitral annular velocities, and LVOT peak
radient, underscoring the influence of LVOT
bstruction on longitudinal myocardial perfor-
ance (62). In a recent report of patients with
stablished HCM, low lateral mitral annular sys-
olic velocity (4 cm/s) was found to have prog-
ostic value and independently predicted death or
ospitalization for worsening heart failure (63).
Tissue Doppler interrogation permits quantifica-
ion of velocity vectors parallel to the ultrasound
eam but being a Doppler-based technique, is
imited by its inherent inability to appraise regions
onparallel to the ultrasound beam (angle-
ependence). Consequently, the utility of pulsed
ave TDI in the assessment of regional longitudi-
al myocardial velocities is restricted to the apical
iews (64). Although TDI provides an assessment
f regional myocardial function, it measures abso-
ute tissue velocities and not myocardial deforma-
ion (Figs. 2A and 2B) and is therefore influenced
y cardiac translational motion and tethering
65,66). These limitations led to the development
f more sophisticated echocardiographic tech-
iques, including TDI-derived myocardial strain
nd strain rate imaging, which hinge on analysis of
elative changes in tissue Doppler velocities ob-
ained using TDI. 1he use of TDI-derived strain in the assessment of
CM. Although TDI was initially advocated as a
echnique for assessing regional myocardial perfor-
ance, its inability to discern myocardial contrac-
ility from passive motion led to the development of
train imaging. In contradistinction to TDI, which
xamines myocardial motion relative to the trans-
ucer, strain assesses myocardial motion relative to
he adjacent myocardium (20).
Systolic myocardial strain () is a dimension-less
uantity and a measure of tissue deformation.
hen the left ventricle contracts, the myocardium
hortens longitudinally and circumferentially (neg-
tive strain) and lengthens or thickens in the radial
irection (positive strain). Strain rate (SR) repre-
ents the local rate of myocardial deformation (67).
nlike tagged cardiac magnetic resonance (CMR),
issue Doppler-based strain imaging (SRI) allows
or the accurate estimation of regional myocardial
eformation with high spatial and temporal resolu-
ion. The discriminatory value of SRI over TDI for
he assessment of regional myocardial function is
idely recognized and was elegantly demonstrated
n an experimental model of intracoronary alcohol
eptal ablation that compared TDI and SRI mea-
urements before and after ablation therapy (32). In
ontrast to TDI, SRI after ablation accurately
dentified areas of discrete regional infarction, reit-
rating its superiority over TDI for the objective
uantification of regional dysfunction.
TDI-derived strain was first used for the evaluation
f HCM by Weidemann et al. (68) in a case report of
child with nonobstructive HCM. Tissue Doppler
elocities were found to be normal in all the septal
egments interrogated. However, systolic longitudinal
as well as SR were significantly decreased “more
ositive” (9%; SR0.9 s1) in the mid septal
egion with no significant changes in the basal (
19%; SR  1.8 s1) or apical ( 23%; SR 
1.6 s1) regions when compared with normal
alues obtained from 30 healthy children. Subse-
uently, Yang et al. (69) reported the assessment of
egional myocardial function in 31 adults with
CM diagnosed echocardiographically. Longitudi-
al strain  was estimated at the basal, mid, and
pical segments of the septal and lateral walls. It was
ignificantly reduced in the septal segments of
atients with HCM compared with control pa-
ients. More importantly, within the septum, mid-
eptum  was significantly diminished and “less
egative” compared with basal and apical segments
1.3  8.2% vs. 12.2  8.7% and 17.3 
0.4%, respectively). In fact, in 54% of the patients
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792ith HCM,  had a positive value (paradoxical
ystolic expansion) (Fig. 2B). A significant correla-
ion was observed between the extent of midseptal 
bnormality and the well-accepted interventricular
eptum/posterior wall ratio, (r  0.81, p  0.01).
idseptal thickness was significantly greater in
egments with positive interventricular septal 
Figure 2. Tissue Doppler Imaging (TDI) and TDI-Derived Strain
(A) Myocardial tissue Doppler velocity tracings from 4 representativ
attenuated systolic and early diastolic velocities from disparate ROIs
in the same areas shown in (A) and corresponding parametric colo
“paradoxical strain” (blue and green tracings) in 2 of the 4 depicte
(yellow tracing). Note striking heterogeneity of strain tracings in co
aortic valve closure; other abbreviations as in Figure 1.ompared with those with negative . This study, Hlong with the case reported by Weidemann et al.
68), highlight the relevance of myocardial disarray
nd fibrosis on regional performance (rapidly and
eproducibly detected by strain imaging), because
he commonly affected midseptum typically shows
he greatest degree of dysfunction.
Longitudinal deformation abnormalities in
ssment in Patients With HCM
gions of interest (ROIs) in a patient with HCM. Note signiﬁcantly
the septum. (B) Tissue Doppler-derived longitudinal strain curves
ain map. Note positive longitudinal strain (systolic lengthening) or
Is (basal septum) and attenuated longitudinal strain elsewhere
st to tissue Doppler data. AVO  aortic valve opening, AVC Asse
e re
in
r str
d RO
ntraCM often are focal or subsegmental and may be
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793nderestimated when conventional segmental
echniques are used to estimate myocardial strain.
engupta et al. (70) compared  values using a
onventional technique to linear mapping in 20
ealthy volunteers and 20 individuals with
CM. Fifteen of the HCM patients had asym-
etrical septal hypertrophy, while 5 had gener-
lized hypertrophy. With the conventional tech-
ique paradoxical strain (systolic lengthening)
as encountered in 45% of the HCM patients
resenting at least 1 segment of “positive” strain.
n contrast, linear mapping detected “positive
train” in 80% of the population studied, remark-
bly enhancing the yield of this diagnostic tool.
dditionally, linear mapping identified post-
ystolic thickening or additional longitudinal
ontraction reflecting spatial nonuniformity (re-
ional dyssynergy) of myocardial function in 50%
Figure 3. Echocardiographic Diagnosis of Apical Hypertrophic C
(A) Contrast-enhanced images (Deﬁnity; Bristol-Myers Squibb Medic
hypertrophic cardiomyopathy in end-diastole and (B) “ace of spade
tion in end-systole. (C) Conventional apical 4-chamber view showin
(quad format) images of same patient showing paradoxical apical lo
perturbations in the color M-mode of the parametric strain map. Nof patients with HCM. These data suggest that lhe heterogeneity of myocardial function in
CM ranges from focal subsegmental to larger
egmental abnormalities and emphasize the need
or careful spatial mapping to increase diagnostic
ield. This effort, in our experience, can be
acilitated by information gleaned from paramet-
ic color strain maps.
Further clinical applications of TDI strain imag-
ng include its role in the accurate differentiation of
CM from asymmetrical hypertensive LVH. Kato
t al. (44) studied 34 patients evaluated for LVH.
ll patients underwent echocardiography, diagnos-
ic cardiac catheterization, as well as endomyocar-
ial biopsy. Twenty patients were diagnosed with
CM on the basis of tissue pathology, used as the
old standard, and the remaining 14 patients had
ypertensive LVH. These investigators reported
hat only septum/posterior wall thickness and epsi-
iomyopathy
aging Inc., North Billerica, Massachusetts) of a patient with apical
pearance of the left ventricle cavity with apical cavity oblitera-
uberant LVH (arrow) in apical HCM. (D) Two-dimensional strain
tudinal strain (crimson segment and tracing) and corresponding
oss of base-apex (strain) gradient.ard
al Im
s” ap
g ex
ngion systolic  were each able to discriminate HCM
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794atients from hypertensive LVH. An epsilon ()
alue of –10.6% was found to have a sensitivity of
5%, specificity of 100%, and a predictive accuracy
f 91.2% for the diagnosis of HCM. Finally,
ost-systolic shortening implying segmental or fo-
al/subsegmental myocardial contraction occurring
emporally after the completion of ejection (aortic
alve closure), detected by strain imaging, is com-
on and has been implicated in the etiology of
iastolic dysfunction in HCM (70,71). Several
stablished, as well as more recent, echocardio-
raphic parameters of diagnostic value in HCM
long with their respective diagnostic accuracies
ave been itemized in Table 1.
D strain or speckle tracking imaging. This rapidly
xpanding technology entails spatial and temporal
racking of adjacent naturally occurring acoustic
arkers or “speckles” from standard black and
hite echocardiographic images in 2 dimensions.
eformation is calculated on a frame-frame anal-
sis of speckle displacement, yielding angle-
ndependent parameters of myocardial contraction,
amely longitudinal, and transverse strain and
train rate (long-axis images). Similarly, radial and
ircumferential strain or strain rate may be mea-
ured off the short-axis images (25). Transverse and
Three-Dimensional Echocardiography
of a parasternal long-axis view obtained using real-time 3-dimen-
ging, angulated to depict systolic anterior motion of the anterior
et (SAM) in a patient with obstructive HCM. Abbreviations as inadial strains represent systolic radial deformation 1r thickening (expressed positively), whereas longi-
udinal and circumferential strains represent percent
ystolic shortening (negative values). The use of 2D
train or speckle tracking imaging overcomes the
imitation of TDI-derived strain when tissue defor-
ation in areas nonparallel to the insonating ultra-
ound beam (angle-independence) are assessed and
as been well validated against tagged CMR and
onomicrometry (72,73)
Leitman et al. (74) first reported on the feasibility
f 2D strain and compared the newly developed
oftware with standard myocardial velocities, longi-
udinal , and SR derived from TDI in healthy
olunteers and patients who experienced a previous
yocardial infarction. Longitudinal strain () and
R were used as indexes of longitudinal myocardial
eformation. These authors found that providing
mage quality and tracking of segments of interest
as adequate, myocardial tissue velocities, 2D ,
nd SR did not significantly differ from those
btained by TDI, with the advantage of simplicity
nd accuracy. However, satisfactory tracking of
nfarcted segments remained suboptimal (80%)
ompared with 98% of normal segments. Interest-
ngly, a base-apex gradient was described, with a
rogressive increase in longitudinal  values noted
rom basal to apical segments.
Subsequently, Serri et al. (25) applied 2D
train echocardiography to a subset of patients
ith familial nonobstructive HCM. Average lon-
itudinal  was reduced in affected individuals
ompared with healthy controls (15.1  6.2%
s. 20.3  5.6%), despite apparently normal
ystolic function (with the use of standard crite-
ia). No significant difference in the values ob-
ained by TDI versus 2D  was observed. Fur-
hermore, transverse, circumferential, and radial
train were significantly reduced in affected indi-
iduals (23.3  17% vs. 27.2  14.9%, 16.8 
.1% vs. 19.6  5.2%, 25.2  13.9% vs. 36.8 
7.2%, respectively). Although overall longitudi-
al  values were reduced in the HCM group, a
ase to apex gradient was still observed, as in the
ontrol group. Similarly, radial strain in the mid-
nd apical short-axis segments in HCM was
ignificantly attenuated compared with patients
ith hypertensive LVH (30). The authors con-
luded that 2D  can be used to identify subclin-
cal global systolic dysfunction in patients with
CM, with improved interobserver as well as
ntraobserver variability compared with TDI-
erived strain (7.5% vs. 13.7% and 7.9% vs.Figure 4.
Still frame
sional ima
mitral leaﬂ4.5%, respectively).
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795A recent study of patients with HCM and
reserved systolic function demonstrated attenu-
ted longitudinal strain, increased circumferential
train, and normal overall systolic LV twist or
orsion (75). Similar observations were reported
n a prior study (23) that used TDI to assess
orsional deformation at rest and during submaxi-
al exercise. In this study, despite preserved LV
ystolic twist and near normal untwisting veloci-
ies at rest, patients with HCM exhibited a
rofound reduction in the magnitude of untwist-
ng velocity with exercise compared with normal
ubjects (23).
Because of its intrinsic ability to provide angle-
ndependent strain data, 2D strain holds a unique
dvantage over tissue Doppler-derived strain,
hich is particularly relevant when one analyzes
yocardial deformation in the apical LV seg-
ents. We recently reported 2 cases of apical
CM in which 2D strain imaging revealed
Table 1. Echocardiographic Features of Diagnostic Value in Hyp
Echocardiographic Modality and Criterion Sensitivity/Sp
2D echocardiography
Asymmetric septal hypertrophy Speciﬁcity 90%
Interventricular septum thickness/posterior wall
IVS/PW ratio 1
Sensitivity 76%
Speciﬁcity 93%
Interventricular septum thickness IVS 15 mm
M-mode
SAM Speciﬁcity 97%
SAM of the anterior mitral leaﬂet or chordae
tendineae
Sensitivity 82%
Speciﬁcity 99%
Tissue Doppler
Sa tissue velocity at the lateral/septal mitral
annulus
Lateral 13 cm
Sensitivity 100
Speciﬁcity 93%
Septal 12 cm
Sensitivity 100
Speciﬁcity 93%
Ea tissue velocity at the lateral/septal annulus Lateral 14 cm
Sensitivity 100
Speciﬁcity 90%
Septal 13 cm
Sensitivity 100
Speciﬁcity 90%
Ea tissue velocity (average) at the mitral
annulus
15 ejection
fraction 68
Sensitivity 44%
Speciﬁcity 100
Sa tissue velocity (average) at the mitral
annulus
9 cm/s†
Sensitivity 8
Speciﬁcity 9
Strain (tissue Doppler imaging)
Systolic longitudinal strain ()  10.6%
Sensitivity 8
Speciﬁcity 1
*Predicted genotype; †differentiated from physiologic LVH.
Ea  early mitral annular diastolic tissue velocity; HCM  hypertrophic cardiom
ventricular hypertrophy; Sa  systolic mitral annular tissue velocity; SAM  sysaradoxical longitudinal strain (systolic lengthen- nng) in the apical segments (9.2% and 16% in
atients #1 and #2, respectively) (76). In contrast
o previous reports (25,74), we observed attenu-
ted longitudinal  values in the mid and distal
egments of the LV, findings suggesting a loss of
he normal base-apex gradient, in this particular
henotype of HCM (Fig. 3).
For nonapical variants of HCM, the TDI–strain
echnique offers the flexibility of linear mapping and
nterrogation of focal areas within the myocardium
unlike 2D strain, which displays average segmental
train), improving diagnostic yield, and should be the
referred method for screening patients with subclin-
cal disease or confirming clinically manifest HCM.
s alluded to earlier in this work, segmental post-
ystolic contraction or shortening representing an
dditional wave of contraction after aortic valve clo-
ure is observed frequently in patients with HCM,
schemia, infarction, and in a small percentage of
ealthy individuals. This phenomenon can be recog-
ophic Cardiomyopathy
city Population
n  1,600 patients
Genetically proven HCM versus nonaffected family members
(n  69)
Genetically proven HCM versus nonaffected family members
n  1,600 patients
Genetically proven HCM versus nonaffected family members
Mutation-positive familial HCM (without LVH) versus gender-
and age-matched control patients (n  60)
Mutation positive familial HCM (without LVH) versus gender-
and age-matched control patients
Mutation positive HCM (with and without LVH) versus age-
matched controls (n  72)
HCM versus HTN and athletes (n  60); heterogeneity of
velocities differentiated from hypertensive LVH
Biopsy-proven HCM versus hypertensive LVH (n  50)
athy; HTN  hypertension; IVS/PW  interventricular septum/posterior wall ratio;
anterior motion.ertr
eciﬁ Reference
Maron et al. (34)
Solomon et al. (60)
Solomon et al. (60)
Maron et al. (34)
Solomon et al. (60)
/s
%
/s
%
Nagueh et al. (26)
/s
%
/s
%
Nagueh et al. 26)
%*
%
Ho et al. (61)
7%
7%
Vinereanu et al. (19)
5%
00%
Kato et al. (44)
yop LVH  left ventricular leftized in strain traces when 2D strain or TDI-based
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796train imaging are used, and needs to be differentiated
rom electromechanical delay in contraction or dys-
ynchrony (70).
hree-dimensional echocardiography. The use of
D-E has provided insights into the mechanics of
AM and deformational geometry of the LV out-
ow tract (Fig. 4) (77). Data suggest that the
edial segments of the mitral valve are predomi-
antly involved in SAM, resulting in a narrow
aterally located LVOT in patients with obstructive
ardiomyopathy (78). Likewise, 3D-E facilitates
he assessment of LVOT area after intervention for
eptal reduction (79) and after surgical myectomy
80), volumetric estimates of left atrial mechanical
unction (81), and accurate estimation of LV ejec-
ion fraction as well as LV mass in hypertrophied
earts (comparing favorably with CMR imaging)
82). Live 3D-E also improves recognition of loca-
Proposed Algorithm for the Diagnosis and Risk Stratiﬁcation of P
sverse LA diameter; **difference between the longest and shortest Q
otion by TDI) among 4 different LV basal myocardial segments
sterior wall ratio; LA  left atrial; LAVI  left atrial volume index; LV
outﬂow tract; RT-3DE  real time-3 dimensional echocardiography;
2 dimensional speckle tracking imaging.ion and extent of LV cavity obliteration (83) and vay be used in conjunction with LV contrast
pacification for this purpose (84).
ontrast echocardiography. Contrast echocardiogra-
hy currently is used to enhance endocardial defi-
ition, Doppler signals, and to evaluate myocardial
erfusion. Although not systematically studied, a
otential role for contrast enhancement in the
iagnosis of apical HCM has been demonstrated
Figs. 3A and 3B) (33). Likewise, contrast-
nhanced 3D-E may also be well suited for the
iagnosis of this entity (84), eliminating the need
or LV angiography or more expensive imaging
odalities such as CMR. Finally, myocardial
ontrast echocardiography can help anticipate the
ocation and delineate the extent of septal infarct
selective injection of contrast into septal perfo-
ators) before alcohol septal ablation (85).
ntraventricular dyssynchrony and prognosis. Inter-
nts With Suspected HCM
time intervals (beginning of Q-wave in ECG to onset of systolic
M  hypertorphic cardiomyopathy; IVS/PW  interventricular
eft ventricular; LVH  left ventricular hypertrophy; LVOT  left
 systolic anterior motion; TDI  tissue Doppler imaging;Figure 5. atie
*Mean tran -Sm
annular m . HC
septum/po  l
ventricular SAMentricular and intraventricular delay is commonly
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797ncountered in patients with HCM, despite the ab-
ence of conduction abnormalities on surface electro-
ardiogram, and appears to correlate to the degree of
eptal LVH and the presence of LV outflow obstruc-
ion (29). Significant temporal heterogeneity of LV
ontractility when speckle tracking imaging-based
easurements of peak radial and circumferential
train are used has been reported in patients with
CM compared with hypertensive LVH and age-
atched control patients (30). The prevalence and
egree of LV dyssynchrony was significantly greater in
atients with HCM compared with hypertensive
VH and age-matched control patients (but not
ignificantly different between the latter entities) (30).
he authors of another study of 123 patients with
CM assessed systolic intraventricular dyssynchrony
y using tissue Doppler and identified a strong asso-
iation between the degree of intraventricular dyssyn-
hrony and extent of LVH. In this study, an intra-
entricular delay of 45 ms, predicted an increased
isk for ventricular tachyarrhythmias and sudden car-
iac death at 5-year follow-up (85.5% sensitivity;
0.4% specificity; positive predictive value: 66.9%; neg-
tive predictive value: 96.7%; test accuracy: 88.8%) (28).
tudy limitations. Despite the tremendous advances
n imaging technologies, there remain limitations to
he routine application of 3D-E (suboptimal spatial
nd temporal resolution) and 2D strain analysis
nsuing from their inherent dependence on image
uality. Another practical limitation is the variabil-
ty in radial strain measurements resulting from
djusting endocardial border tracings and the width
f the region of interest. Further refinements in
D-E may allow speckle tracking in 3D, facilitatingfor familial hypertrophic cardiomyop- Bernabo P, Bruzzechanics. The drawbacks of TDI analysis include
ngle-dependence and its susceptibility to signal
oise that can influence peak velocity measures and
DI-derived strain data. Notwithstanding these
imitations, in our opinion, TDI and strain imag-
ng, particularly longitudinal strain linear mapping,
hould be incorporated into the routine diagnostic
ssessment of suspected HCM and screening of
amily members. Demonstration of focal or seg-
ental areas of paradoxical strain can provide in-
remental information and consolidate the diagno-
is of suspected or equivocal HCM, assessed by
onventional echo techniques (Table 1). Pending
urther refinements, an algorithm incorporating
ovel parameters is presented to assist the clinician
ith a practical approach to the diagnosis and risk
tratification of HCM (Fig. 5).
onclusions
t this time, tissue Doppler-derived strain and 2D
train or speckle tracking imaging represent robust
nd rapidly evolving technologies that have ad-
anced our understanding of regional myocardial
echanics in HCM. Ongoing refinements and
dditional research will define the incremental role
nd clinical utility of these promising techniques,
ncluding the identification of preclinical disease in
arriers of HCM mutations, improvement of diag-
ostic accuracy, risk stratification, planning thera-
eutic strategies, and monitoring treatment.
eprint requests and correspondence: Dr. Theodore P.
braham, Johns Hopkins University, 600 North Wolfe
treet, Carnegie 568, Baltimore, Maryland 21287.more comprehensive assessment of regional LV E-mail: tabraha3@jhmi.edu.1
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